ScholarGate
Trợ lý

So sánh phương pháp

Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.

Thử nghiệm lâm sàng Giai đoạn III có đối chứng×Giai đoạn III Thử nghiệm lâm sàng×
Lĩnh vựcDịch tễ họcDịch tễ học
HọProcess / pipelineProcess / pipeline
Năm ra đờiMid-20th century (matching in RCTs formalized ~1950s–1970s)1962 (Kefauver-Harris Amendment formalised phased drug development)
Người khởi xướngFisher, R. A. (matching principles); adapted into confirmatory trial design over mid-20th centuryFDA regulatory framework / ICH guidelines
LoạiControlled confirmatory clinical trial with matchingConfirmatory randomised controlled trial
Công trình gốcRothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385
Tên gọi khácmatched controlled Phase III trial, Phase III matched-pair trial, matched confirmatory trial, matched late-phase RCTPhase 3 trial, confirmatory trial, pivotal trial, Phase III RCT
Liên quan56
Tóm tắtA matched Phase III clinical trial is a confirmatory, late-stage controlled study in which each participant assigned to the experimental treatment is paired with one or more controls who share key prognostic characteristics — such as age, disease stage, or comorbidities — before treatment allocation. By ensuring baseline comparability at the level of matched pairs, the design reduces confounding and improves statistical efficiency in settings where simple randomization alone may produce imbalanced groups or where full randomization is logistically or ethically constrained.A Phase III clinical trial is a large-scale, confirmatory randomised controlled trial designed to establish the efficacy and safety of an intervention in the target patient population before regulatory submission. It builds on the signal identified in Phase II, tests the intervention at its proposed dose under controlled conditions, and provides the primary evidence base for marketing authorisation or guideline adoption.
ScholarGateBộ dữ liệu
  1. v1
  2. 2 Nguồn tài liệu
  3. PUBLISHED
  1. v1
  2. 2 Nguồn tài liệu
  3. PUBLISHED

Đến trang tìm kiếm Tải xuống bản trình chiếu

ScholarGateSo sánh phương pháp: Matched Phase III Clinical Trial · Phase III clinical trial. Truy cập ngày 2026-06-20 từ https://scholargate.app/vi/compare